Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Sirona Biochem CEO Quarterly Update

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Apr 11, 2022 9:44am

151 Views

Post# 34593261

RE:RE:RE:Sirona Biochem CEO Quarterly Update

Investing is about predicting the future, not crying about the past.

Whether you like them or not, money is money and it really does appear they have at least one or two big rabbits here.

The update here in my opinion is the factual reference point for "I told you so".

Let's go Sirona!

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec